Characteristics associated with use of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in Burkina Faso, Democratic Republic of Congo, and Uganda. [PDF]
Contracept X, 2021 To what extent is DMPA-SC reaching new users versus encouraging method switching among existing users? Though increasingly-popular, little is known about characteristics of women using DMPA-SC in SSA. We compared characteristics of women using DMPA-SC with those of other modern methods, and identified the extent to which women using DMPA-SC switched ...
Anglewicz P +7 more
europepmc +4 more sources
Introduction of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) Injectable Contraception at Facility and Community Levels: Pilot Results From 4 Districts of Uganda. [PDF]
Glob Health Sci Pract, 2018 Reproductive Health Uganda (RHU), a local NGO, introduced subcutaneous depot medroxyprogesterone acetate (DMPA-SC, brand name Sayana Press) in 4 districts of Uganda between April 2016 and March 2017.
Odwe G +4 more
europepmc +2 more sources
Self-injected contraceptives: does the investment reflect women’s preferences?
BMJ Global Health, 2022 Subcutaneous depot medroxyprogesterone acetate (DMPA-SC) is an innovative contraceptive method aimed at meeting women’s unique circumstances and needs, largely due to its ability to be self-injected.
Sophia Magalona +8 more
doaj +1 more source
PLoS ONE, 2022 Objective While self-injection of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) has well-documented benefits, uptake may be improved by addressing client concerns such as fear of self-injury and low self-efficacy.
Holly M. Burke +7 more
doaj +2 more sources
Task-shifting the provision of DMPA-SC in the DR Congo: Perspectives from two different groups of providers. [PDF]
Contraception, 2018 To document the experience of three groups of Family Planning service providers participating in task-shifting for the provision of subcutaneous depot-medroxyprogesterone acetate (DMPA-SC) at the community level in the DRC.This article compares results from interviews with DMPA-SC providers in two separate pilot studies: 1) 53 medical and nursing ...
Hernandez JH +5 more
europepmc +4 more sources
Introduction of Community-Based Provision of Subcutaneous Depot Medroxyprogesterone Acetate (DMPA-SC) in Benin: Programmatic Results. [PDF]
Glob Health Sci Pract, 2019 The Republic of Benin faces high maternal, newborn, and child mortality; low modern contraceptive use; and a critical shortage of health workers. In 2013, the Government of Benin made 3 reproductive health commitments to improve national health indicators, including expanding provision of family planning services at the community level through task ...
Okegbe T +7 more
europepmc +4 more sources
An Observational Study to Test the Acceptability and Feasibility of Using Medical and Nursing Students to Instruct Clients in DMPA-SC Self-Injection at the Community Level in Kinshasa [PDF]
Contraception, 2018 Jane Bertrand +2 more
exaly +2 more sources
, 2022 DMPA-SC is a lower-dose, easy-to-use injectable contraceptive. A trained person can administer it, including women through self-injection. This systematic review aims to assess the effectiveness of self- versus provider-administered contraceptive DMPA-SC
Ashraf Nabhan
core +1 more source
An implementation project to expand access to self-administered depot medroxyprogesterone acetate (DMPA) [PDF]
, 2020 ObjectiveTo describe the implementation and results of a proactive patient outreach project to offer self-administered, depot medroxyprogesterone (DMPA) subcutaneous (SC) to interested patients at a California safety-net clinic following expanded state ...
O'Grady, Niamh +6 more
core +1 more source
Systematic Reviews, 2023 Background Self-administered depot medroxyprogesterone acetate subcutaneous injectable contraception (DMPA-SC) is registered in many countries. It shows great potential for improving contraceptive access, continuation, and autonomy.
Adeniyi Kolade Aderoba +2 more
doaj +1 more source